Vasculitis Trial, Recruiting NCT07151521 Sponsor: Ruijin Hospital Condition: Vasculitis
Back to Vasculitis

Vasculitis Trial, Recruiting

NCT07151521
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years of age or older
  • You must have been diagnosed with a condition called ANCA-associated vasculitis, based on recognized 2022 medical guidelines
  • You must also have a lung condition called interstitial lung disease, confirmed by a specialised type of chest scan (CT scan) taken within the past year and reviewed by two radiologists
  • Your medical records and health information must be complete and available
  • You must be willing to sign a consent form agreeing to take part in the study
  • You must be willing and able to follow the study's procedures for the full duration of the trial

Who may not be able to join:

  • You have another rheumatic (joint or immune system) disease in addition to the one described above
  • You have a condition that could itself cause lung disease or kidney problems, such as lupus, dermatomyositis, or rheumatoid arthritis
  • You have previously had, or are planning to have, a stem cell transplant (a procedure involving replacing blood-forming cells)
  • You have serious health problems that the trial doctors consider too risky for participation, such as severe heart or lung failure, severe bone marrow problems, or severe liver or kidney failure
  • You have a serious and urgent stomach or bowel problem, such as a hole in the intestine or a complete bowel blockage
  • You are pregnant, possibly pregnant, or currently breastfeeding
  • You are unlikely to follow the treatment plan or study requirements as agreed (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8617721375702

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 July 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Disease severity and activity in ANCA-associated vasculitis with concomitant interstitial lung disease and renal dysfunction as measured by 68Ga-FAPI PET/CT.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov